Lung cancer is the leading cause of cancer-related death in the world. It is broadly divided
into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx …

Background The identification of surgical non-small cell lung cancer (NSCLC) patients with
poor prognosis is a priority in clinical oncology because of their high 5-year mortality. This …

Purpose To update literature-based recommendations for techniques used in high-precision
thoracic radiotherapy for lung cancer, in both routine practice and clinical trials. Methods A …

Despite progressive improvements in the management of patients with locoregionally
confined, advanced-stage solid tumours, distant metastasis remains a very common—and …

Purpose To study the risk factors for radiation-induced lung toxicity (RILT) after stereotactic
body radiation therapy (SBRT) of the thorax. Methods and Materials Published studies on …

BACKGROUND The authors evaluated the efficacy, patterns of failure, and toxicity of
stereotactic ablative radiotherapy (SABR) for patients with medically inoperable, clinical …

Purpose As no completed randomized trials of surgery versus stereotactic ablative radiation
therapy (SABR) in patients with early-stage non-small cell lung cancer are available …

Objectives Stereotactic body radiotherapy is an effective treatment for patients with early-
stage non–small cell lung cancer who are not healthy enough to undergo surgery; however …

Purpose Stereotactic body radiation therapy (SBRT) has become the standard of care for
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …

The use of stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung
cancer is growing rapidly, particularly since it has become the recommended therapy for …